To assess the relevance of the afore-mentioned results for T-ALL patients in the clinical setting, we evaluated the transcriptional level of CLOCK, BMAL1 and IL20RB genes in a cohort of 264 diagnostic T-ALL patients’ samples from the COG TARGET study [4]. This evidence concerns the gene CLOCK and acute lymphoblastic leukemia.